 total androgen ablat canadian experi multicent double-blind trial total androgen blockad use castrat pure anti-androgen simpl castrat patient treatment orchiectomi placebo sever featur efficaci bone pain treatment month number favor respons npcp criteria simpl castrat treatment signific differ group time progress logrank test surviv logrank test increas median surviv month measur differ treatment total androgen blockad patient progress year dead year review result similar studi improv modest improv total androgen blockad testicular androgen ablat